Overview

Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Determination of guidelines regarding the use of adjuvant chemotherapy for early breast cancer in this population of Patients over 70 years old.
Phase:
Phase 2
Details
Lead Sponsor:
Jules Bordet Institute
Treatments:
Capecitabine